Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07455747 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Real-World Treatment of Extracranial Carotid Artery Disease With the ENROUTE™ Transcarotid Neuroprotection System

Name: Real-World Treatment of Extracranial Carotid Artery Disease With the ENROUTE™ Transcarotid Neuroprotection System — clinical trial record (NCT07455747)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ENTRUST

StatusRecruiting

PhaseNot specified

SponsorBoston Scientific Corporation

Started2026-08-19

View on ClinicalTrials.gov ↗

Amendment history

2026-09-24

Recruitment opened

2026-07-15

Study Status v4

Start date2026-06→2026-07

2026-06-16

Study Status v3

Start date2026-05→2026-06

2026-05-15

2 amendments v1-v2

2 re-verifications since 2026-04-10, no change to tracked fields

2026-03-03

Original filing

Boston Scientific Corporation

92 trials monitored

See 9 trials at risk

The ENTRUST registry's objective is to collect real-world data (RWD) and health economic data on the ENROUTE™ Transcarotid Neuroprotection System (ENROUTE™ Transcarotid NPS), including populations in which outcomes of Transcarotid Artery Revascularization (TCAR) in patients with extracranial carotid artery disease are inadequately reported.

Trial Details

NCT Number	NCT07455747
Lead Sponsor	Boston Scientific Corporation
Conditions	Extracranial Carotid Artery Disease, TCAR, Transcarotid Artery Revascularization
Enrollment	5,000 participants
Start Date	2026-08-19
Primary Completion	2028-05 (estimated)
Study Completion	2030-04 (estimated)
Updated on ClinicalTrials.gov	2026-09-23